Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-026162
Date:2021-04-06
Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
Original Submission Date:

Reporting Person:

CAMPBELL BRADLEY L
C/O AMICUS THERAPEUTICS, INC.
3675 MARKET STREET PHILADELPHIA, PA 19104

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-04-06 A 33,165 a $0.00 412,022 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 granted in the form of restricted stock units for the achievement of the 2019 prsu revenue goal. each restricted stock unit represents a contingent right to receive one share of amicus common stock. the restricted stock units will vest on december 31, 2021, subject to the reporting person's continued service with the company.
WhaleWisdom Logo

Elevate your investments